Leerink Partnrs Reduces Earnings Estimates for 908 Devices

908 Devices Inc. (NASDAQ:MASSFree Report) – Analysts at Leerink Partnrs cut their Q4 2025 earnings per share (EPS) estimates for 908 Devices in a note issued to investors on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now expects that the company will post earnings per share of ($0.25) for the quarter, down from their prior forecast of ($0.24). Leerink Partnrs currently has a “Hold” rating on the stock. The consensus estimate for 908 Devices’ current full-year earnings is ($1.99) per share. Leerink Partnrs also issued estimates for 908 Devices’ FY2026 earnings at ($1.10) EPS.

A number of other research analysts also recently commented on the company. Stephens reiterated an “overweight” rating and set a $6.00 target price on shares of 908 Devices in a research report on Wednesday, January 15th. Weiss Ratings reiterated a “sell (e+)” rating on shares of 908 Devices in a research report on Saturday, January 18th. Stifel Nicolaus dropped their price objective on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Finally, Leerink Partners restated a “market perform” rating and set a $4.00 target price (down from $12.00) on shares of 908 Devices in a research report on Wednesday, November 13th. Two analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $5.33.

Get Our Latest Report on 908 Devices

908 Devices Trading Down 1.1 %

Shares of 908 Devices stock opened at $2.78 on Thursday. 908 Devices has a 12 month low of $1.81 and a 12 month high of $8.50. The stock has a 50 day moving average of $2.37 and a 200 day moving average of $3.46. The firm has a market cap of $96.80 million, a PE ratio of -1.57 and a beta of 0.96.

Institutional Investors Weigh In On 908 Devices

Several hedge funds and other institutional investors have recently made changes to their positions in the company. SG Americas Securities LLC bought a new position in 908 Devices during the 3rd quarter valued at about $36,000. B. Riley Wealth Advisors Inc. purchased a new position in shares of 908 Devices during the third quarter valued at approximately $45,000. Drive Wealth Management LLC bought a new position in shares of 908 Devices during the third quarter valued at approximately $50,000. Townsquare Capital LLC purchased a new stake in shares of 908 Devices in the third quarter worth approximately $50,000. Finally, 49 Wealth Management LLC lifted its stake in shares of 908 Devices by 16.2% during the 3rd quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock worth $108,000 after acquiring an additional 4,343 shares during the last quarter. Hedge funds and other institutional investors own 88.06% of the company’s stock.

908 Devices Company Profile

(Get Free Report)

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.

Recommended Stories

Earnings History and Estimates for 908 Devices (NASDAQ:MASS)

Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.